John Walsh
Acute Care · South Bend, INNPI 1316427560
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Johnson & Johnson at 44.7% of the total. Reporting peaked in 2022 at $622 and has fallen 64.6% since, to $220 in 2025.
Across 60 payments — averaging $24.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$646
- Actelion Pharmaceuticals US, Inc.$169
- Zimmer Biomet$92
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$57
- Orexo US, Inc.$51
- Amgen$33
- plus $396 from 19 others
What the payments were for
- Food & beverage$1,33993%
- Education$775%
- Other$282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $646 |
| Actelion Pharmaceuticals US, Inc. | 5 | $169 |
| Zimmer Biomet | 1 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $57 |
| Orexo US, Inc. | 3 | $51 |
| Amgen | 2 | $33 |
| AstraZeneca | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Baxter Healthcare | 1 | $28 |
| Merck | 2 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Cerus Corporation | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Vertex | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Haemonetics Corporation | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| Indivior Inc. | 1 | $16 |
| Novartis | 1 | $14 |
| Davol Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$337
How this compares
$1,445 in reported general payments places this provider in the 75th percentile of 240 acute care providers in Indiana.
Other acute care in South Bend
- Erin BarthSouth Bend$10K
- Janaye KeiferSouth Bend$3K
- Melissa LorenzJeffersonville$19K
- Amara Wright-TerryMunster$17K
- Wen CaiNewburgh$12K
- Sarah LongNewburgh$8K
- Aaron HoldermanNewburgh$8K
- Lauren ArmingtonIndianapolis$7K
- Ashley HillIndianapolis$7K
- Sara RichesonNewburgh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.